Apr 16, 2025 / 11:00AM GMT
Operator
Ladies and gentlemen, welcome to the Sartorius and Sartorius Stedim Biotech conference call on the first quarter 2025. (Operator Instructions)
At this time, it's my pleasure to hand over to Dr. Joachim Kreuzburg. Please go ahead, sir.
Joachim Kreuzburg - Sartorius AG - Chairman of the Executive Board, Chief Executive Officer
Thank you very much for the introduction. And hello and welcome to our conference call on the Q1 results of Sartorius AG, as well as Sartorius Stedim Biotech. Today, I'm together with Florian Funck, our CFO; as well as with René Fáber, the President of our Bioprocessing division, as well as the CEO of Sartorius Stedim Biotech; and also Alexandra Gatzemeyer, the President of our Lab division, as she will walk you through the slide on the most recently announced acquisition of MatTek.
So let me start with walking you through the highlights of the first quarter of 2025. We think we are off to a good start -- a very good start into the year 2025. Pretty much development has been as expected.
That means very much
Q1 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Apr 16, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers